.webp?width=217&height=60&name=Screenpoint-Med%20(1).webp "Screen Point Medical")
%20(1).png)
MASAI RCT: 12% reduction in interval cancer rate using Transpara
.png)
New book from Joanna Stern highlights personal breast cancer journey
.png)
Transpara® Breast AI Selected for $16M PRISM Randomized Controlled Trial in USA
.png)
ScreenPoint Medical Enables Transpara® Breast AI within Precision Imaging Network, part of Microsoft for Healthcare
ScreenPoint Medical has now made its Transpara® breast-imaging AI portfolio available through Precision Imaging Network, part of Microsoft for Healthcare.
.png)
ScreenPoint Medical Showcases Transpara Breast AI Suite at RSNA 2025
Transpara Breast AI solutions outperform the competition at RSNA 2025, capping a year of growth and forward momentum for ScreenPoint Medical.
.png)
RAYUS Radiology adopts Transpara® Breast AI
RAYUS Radiology announces its partnership with ScreenPoint Medical and its adoption of Transpara Breast AI in Washington State.
.png)
Transpara Announces New FDA Clearance at RSNA 2024
SPM Showcases Innovative FDA Cleared Capabilities including Breast Density Assessment and Temporal Comparison to Elevate Radiologist Performance
.png)
ScreenPoint Medical Leadership Transition: Pieter Kroese Confirmed as CEO
Pieter Kroese appointed as the Chief Executive Officer of ScreenPoint Medical, effective April 25, 2024.
.png)
ScreenPoint Medical Deploys Transpara® Breast AI at Johns Hopkins to Improve Cancer Detection
Transpara implemented for clinical use by key thought leaders in radiology and breast imaging.